S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RGNX REGENXBIO Inc

8.51

0.30 (3.65%)

Pre Market

Last Updated: 04:26:23

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more REGENXBIO Charts.

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more REGENXBIO Charts.

REGENXBIO Inc News

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025
Thursday 30 January 2025 (2 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 14 January 2025 (4 weeks ago) • Edgar (US Regulatory)

REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
Tuesday 14 January 2025 (4 weeks ago) • PR Newswire (US)

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
Monday 13 January 2025 (4 weeks ago) • PR Newswire (US)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 30 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 9 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 9 December 2024 (2 months ago) • Edgar (US Regulatory)

Apollo Global Management and Workday Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Friday 6 December 2024 (2 months ago) • PR Newswire (US)

More REGENXBIO Inc News Articles

Kraig Biocraft Laborator... (QB)

Intergrated Cannabis Sol... (PK)

North Bay Resources (PK)

RespireRx Pharmaceuticals (CE)

Code Green Apparel (PK)

Rennova Health (CE)

NioCorp Developments

Bioelectronics (PK)

Lightwave Logic

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Liquidmetal Technologies (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions